Innovus Pharma initiates patient enrollment in post-marketing EjectDelay clinical trial
EjectDelay’s active ingredient is a fast absorbing and vanishing gel formulation with the active drug benzocaine at 7.5% designed to reduce transfer to the partner. A total of